We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$8.04B
AUM Growth
+$164M
Cap. Flow
-$244M
Cap. Flow %
-3.03%
Top 10 Hldgs %
72.74%
Holding
123
New
10
Increased
29
Reduced
37
Closed
40

Top Buys

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$171M
2
ELV icon
Elevance Health
ELV
+$30.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.2M
4
ISRG icon
Intuitive Surgical
ISRG
+$14.8M
5
HUM icon
Humana
HUM
+$13.9M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$139M
2
JNJ icon
Johnson & Johnson
JNJ
+$45.8M
3
ECL icon
Ecolab
ECL
+$41.6M
4
UNH icon
UnitedHealth
UNH
+$33.4M
5
PFE icon
Pfizer
PFE
+$32.3M

Sector Composition

Rank Sector Weight
1 Financials 24.06%
2 Consumer Discretionary 16.59%
3 Healthcare 13.94%
4 Consumer Staples 10.32%
5 Materials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$324B
$22.2M 0.28%
277,673
-68,120
-20% -$5.22M
ISRG icon
27
Intuitive Surgical
ISRG
$127B
$22M 0.27%
125,811
+86,400
+219% +$14.8M
EXAS
28
DELISTED
Exact Sciences
EXAS
$21.1M 0.26%
178,932
+120,000
+204% +$12.1M
ILMN icon
29
Illumina
ILMN
$29B
$20.1M 0.25%
56,031
+41,120
+276% +$13M
DXCM icon
30
DexCom
DXCM
$29.1B
$18.3M 0.23%
487,796
+380,000
+353% +$11.9M
PODD icon
31
Insulet
PODD
$11.7B
$18.2M 0.23%
152,672
+100,000
+190% +$10.3M
SRPT icon
32
Sarepta Therapeutics
SRPT
$1.64B
$17.5M 0.22%
115,329
+90,000
+355% +$10.9M
CNC icon
33
Centene
CNC
$30.8B
$16.6M 0.21%
317,306
+130,000
+69% +$7.02M
GKOS icon
34
Glaukos
GKOS
$9.21B
$15.8M 0.2%
209,265
+165,000
+373% +$11.8M
TDOC icon
35
Teladoc Health
TDOC
$1.67B
$15.6M 0.19%
234,834
+130,000
+124% +$7.58M
TVRD
36
Tvardi Therapeutics
TVRD
$22.1M
$15.1M 0.19%
19,541
+15,556
+390% +$10.9M
CHRS icon
37
Coherus Oncology
CHRS
$217M
$15M 0.19%
678,464
+480,000
+242% +$8.34M
TFX icon
38
Teleflex
TFX
$5.91B
$14.9M 0.19%
+45,000
New +$13.6M
AMRN
39
Amarin Corp
AMRN
$300M
$14.8M 0.18%
38,066
– –
HUM icon
40
Humana
HUM
$43.5B
$14.6M 0.18%
+55,000
New +$13.9M
BMRN icon
41
BioMarin Pharmaceuticals
BMRN
$11.9B
$14M 0.17%
163,851
+95,000
+138% +$8.13M
BHVN
42
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13.7M 0.17%
311,751
-70,000
-18% -$3.95M
AERI
43
DELISTED
Aerie Pharmaceuticals
AERI
$13.5M 0.17%
456,142
+320,000
+235% +$12.3M
LHCG
44
DELISTED
LHC Group LLC
LHCG
$13.2M 0.16%
110,657
+65,000
+142% +$7.33M
NVCR icon
45
NovoCure
NVCR
$1.78B
$13.2M 0.16%
208,059
+100,000
+93% +$5.07M
STML
46
DELISTED
Stemline Therapeutics, Inc.
STML
$13.1M 0.16%
858,082
+500,000
+140% +$7.23M
HRTX icon
47
Heron Therapeutics
HRTX
$92.5M
$13.1M 0.16%
702,069
+450,000
+179% +$8.99M
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$124B
$12.6M 0.16%
68,557
– –
AXDX
49
DELISTED
Accelerate Diagnostics
AXDX
$12M 0.15%
52,468
+41,000
+358% +$8.02M
HZNP
50
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$11.8M 0.15%
491,544
+300,000
+157% +$7.61M
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2019 Portfolio in Review

As of Q2 2019, C WorldWide Group held 123 positions worth $8.04B, up 2.1% from $7.88B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group withdrew a net $244M in Q2 2019, closing 40 positions and reducing 37 holdings. Its most notable exit was Amgen, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, C WorldWide Group opened a new position in MSCI worth $183M.

  • C WorldWide Group's largest Q2 2019 buy was MSCI: 764,587 shares worth $183M.
  • C WorldWide Group added most to Elevance Health in Q2 2019, an estimated $30.9M increase.
  • C WorldWide Group's biggest Q2 2019 reduction was Visa, cutting an estimated $139M.
  • C WorldWide Group fully exited Amgen in Q2 2019, selling an estimated $15.3M.
  • C WorldWide Group's ten largest holdings make up 73% of its $8.04B portfolio in Q2 2019.
  • C WorldWide Group opened 10 new positions and closed 40 in Q2 2019.
  • C WorldWide Group's portfolio value rose 2.1% quarter-over-quarter to $8.04B.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.